{"id":220468,"date":"2026-05-26T09:00:00","date_gmt":"2026-05-26T13:00:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/05\/26\/neurophet-launches-joint-study-with-vhir-on-neurophet-aqua-ms-accelerating-ai-algorithm-validation\/"},"modified":"2026-05-26T14:15:20","modified_gmt":"2026-05-26T18:15:20","slug":"neurophet-launches-joint-study-with-vhir-on-neurophet-aqua-ms-accelerating-ai-algorithm-validation","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/05\/26\/neurophet-launches-joint-study-with-vhir-on-neurophet-aqua-ms-accelerating-ai-algorithm-validation\/","title":{"rendered":"Neurophet Launches Joint Study with VHIR on &#8216;Neurophet AQUA MS&#8217;, Accelerating AI Algorithm Validation"},"content":{"rendered":"<p><a href=\"https:\/\/www.prnewswire.com\/news-releases\/neurophet-launches-joint-study-with-vhir-on-neurophet-aqua-ms-accelerating-ai-algorithm-validation-302778771.html\">Neurophet Launches Joint Study with VHIR on &#8216;Neurophet AQUA MS&#8217;, Accelerating AI Algorithm Validation<\/a><\/p>\n<p><a href=\"https:\/\/www.prnewswire.com\/news-releases\/neurophet-launches-joint-study-with-vhir-on-neurophet-aqua-ms-accelerating-ai-algorithm-validation-302778771.html\">https:\/\/www.prnewswire.com\/news-releases\/neurophet-launches-joint-study-with-vhir-on-neurophet-aqua-ms-accelerating-ai-algorithm-validation-302778771.html<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-05-26 09:00:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.prnewswire.com\">www.prnewswire.com<\/a><\/p>\n<ul>\n<li><strong>Collaboration Announcement<\/strong>: Neurophet, an AI solution company, announced a joint research partnership with Vall d&#8217;Hebron Institut de Recerca (VHIR) to develop AI diagnostics for multiple sclerosis.<\/li>\n<li><strong>Focus on AI Algorithms<\/strong>: The collaboration aims to leverage large-scale clinical brain MRI datasets to develop AI algorithms that can detect key lesion biomarkers in multiple sclerosis.<\/li>\n<li><strong>Development of AQUA MS Software<\/strong>: Neurophet aims to use VHIR\u2019s datasets to integrate and enhance its AQUA MS software, which is designed for analyzing brain images of multiple sclerosis patients.<\/li>\n<li><strong>Key Biomarker Detection<\/strong>: The project will focus on creating detection algorithms for the Central Vein Sign (CVS) and Paramagnetic Rim Lesions (PRL), which are important imaging biomarkers for multiple sclerosis.<\/li>\n<li><strong>Market Focus<\/strong>: The enhanced AI technology from Neurophet aims to establish a strategic foothold in the U.S. and European markets, where the prevalence of multiple sclerosis is higher.<\/li>\n<li><strong>Leveraging VHIR\u2019s Expertise<\/strong>: VHIR will contribute de-identified MRI datasets and expertise, with Dr. Alex Rovira Ca\u00f1ellas leading this effort in enhancing the clinical reliability of Neurophet&#8217;s AI technology.<\/li>\n<li><strong>Product Background<\/strong>: Neurophet\u2019s AQUA MS received FDA 510(k) clearance in October 2024 and is part of a suite of AI-driven products for brain disorder diagnosis and treatment solutions.<\/li>\n<li><strong>Strategic Focus<\/strong>: Neurophet, founded in 2016, is dedicated to developing AI solutions for brain disorders, emphasizing the importance of clinical data in enhancing the efficacy of its technologies.<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neurophet Launches Joint Study with VHIR on &#8216;Neurophet AQUA MS&#8217;, Accelerating AI Algorithm Validation https:\/\/www.prnewswire.com\/news-releases\/neurophet-launches-joint-study-with-vhir-on-neurophet-aqua-ms-accelerating-ai-algorithm-validation-302778771.html&#8230;<\/p>\n","protected":false},"author":1,"featured_media":220469,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/mma.prnewswire.com\/media\/2985112\/Neurophet_Launches_Joint_Study_with_VHIR_on_Neurophet_AQUA_MS.jpg?p=facebook","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[],"class_list":["post-220468","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/220468"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=220468"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/220468\/revisions"}],"predecessor-version":[{"id":220470,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/220468\/revisions\/220470"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/220469"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=220468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=220468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=220468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}